Encouraging results on the effectiveness of the vaccine from the leading vaccination campaigns of countries such as Israel, he helped the optimistic world to push the pandemic.

It is like a "vaccine laboratory" of the world, Israel is one of the countries with vaccination rates on the global highest total population, with 59% injected at least one dose of pfizer and 48% vaccine.

Country more than 9 million people started the vaccination program last December, according to a cooperation agreement with Pfizer / BionTech to study the effectiveness of the Covid-19 vaccine.

The research results published last month in the New England medical journal show that the Pfizer vaccine is effective to 94% in preventing Covid-19 and 92% of symptoms for serious cases.

However, the latest analysis of vaccine-based vaccines of the Israeli Ministry of Health shows that the Pfizer vaccine can prevent the risk of infection and death from Covid-19 to 97%, and effectively for these

"This is clearly evident for the power of Vaccine Covid-19 in the anti-virus war and encouraging us to continue his vaccination campaign," said Professor Yeheskel Levy, representative of the Ministry of Health Israel, said.

Medical staff injected vaccines for her grandmother in Netanya, Israel on January 19.

Israel can promote vaccination campaigns thanks to the universal health system and existing digitization.

Like many other countries, the first stage of Israel's vaccination campaign also focused on the group of people over 60 years old and medical staff.

The promising results recently opened hope for this Middle Eastern country and the world about the war against pandemic.

He used to chaotic in the anti-epidemic strategy, but now it was possible to confidently escaped from Covid-19 thanks to the early "bet" into the vaccine.

He launched the first vaccination campaign for Vaccine Covid-19 in the world in December 2020, largely used vaccines by his pharmaceutical company - Sweden Astrazeneca to develop with Oxford University, with vaccines

Research results of the Public Health Agency Britain (Phe) announced earlier this month indicates that the Pfizer and Astrazeneca vaccine reduces the risk of Covid-19 infection for people over 70 years old.

Since the study began in January, the ability to prevent Covid-19 symptoms of vaccines after 4 weeks of first injections ranging from 57% to 61% for Pfizer and 60% to 73% for Astrazeneca

The study was conducted based on the data of more than 7.5 million people showing that the vaccine was at least risk of symptoms worse than those who were not injected.

"They can help explain why the number of special care diseases in the age group over 80 in the UK has declined in the past few weeks," Matt Hancock's Matt Health Minister said earlier the month.

Although many European countries and the world stopped using Astrazeneca after some people were coagulated, he affirmed that Astrazeneca's Covid-19 vaccine "is safe and effective" and will continue the next vaccination campaign

The United Kingdom United Arab (UAE) on March 16 said more than 52% of the population was vaccinated with Vaccine Covid-19.

"This is a positive step to help the UAE in the national group with the highest vaccination rate in the world," said Health Minister and Prevention Abdul Rahman Al Owais, said.

UAE is currently using mainly Vaccine Sinopharm, China.

After Israel, UAE and England, Chile is also a country located in the first group of vaccination.

The Chilean Finance Ministry said that as a day of March 1, there was a 14 million dose of Sinovac, 10 million doses from Pfizer / Biontech, four million doses of Astrazeneca and four million doses of Johnson & Johnson.

However, amid the achievement of vaccination, Chilean witnessed one of the largest NCOV outbreaks for months.

Paula Daza, the leading Health Officer Chile, warns although 26% of the population was injected a dose of vaccines, people should not loose vigilance.

A box of vaccine Johnson & Johnson was transferred to the hospital in Bay Shore, New York on March 3.

America, the world's largest translation area, distributed more than 109 million vaccines, of which 21% of the population was injected at least one dose and over 12% completed the vaccination program, according to our World in Data.

When many Americans promote back to normal life, US officials are working hard to increase the vaccination rate in the US.

"All current evidence shows that vaccines help reduce non-symptom infections - high-infectious sources", former Member of the US Food and Pharmaceutical Management Agency (FDA) and Member of the Board of Directors

Analysis from Johns Hopkins University shows that new cases in the US as of March 13 decreased by 11% compared to the previous week, continuing to decline recently.

However, a newly announced study of Pfrizer and Moderna showed that the vaccine was less likely to spread the virus if infected as well as less symptoms than the non-injection.

The above data "especially means when we seek to cut off the spread of the virus globally," said Dr. Luis Jodar of Pfizer, said in the press release.